Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Cancer Profiling Market Expected to Grow Between 2025 And 2029?
Over the past years, the market size for cancer profiling has witnessed quick expansion. The market value, which stood at $13.48 billion in 2024, is predicted to increase to $15 billion in 2025, registering a compound annual growth rate (CAGR) of 11.3%. The substantial growth in the past can be credited to factors such as escalating rates of cancer cases, growth in precision medicine methods, the clinical utilization of biomarkers, drug development and targeted therapies, increased awareness, and patient advocacy.
In the coming years, a swift expansion in the cancer profiling market size is projected. It is expected to enlarge to$22.97 billion by 2029 with a compound annual growth rate (CAGR) of 11.2%. Factors such as the incorporation of artificial intelligence in diagnosis, worldwide research collaborations, increased use of liquid biopsy applications, official approval for precision medication, and escalating focus on early detection all contribute to this growth within the forecast period. The forecast period will also witness a surge in liquid biopsy usage, extensive genomic profiling, the increasing prevalence of immunoprofiling, cooperative data sharing networks, and the advent of single-cell sequencing.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Cancer Profiling Market?
The escalating rate of cancer cases is predicted to fuel the expansion of the cancer profiling market. The term incidence of cancer relates to the tallies of new cancer instances within a specific demographic within a defined timeframe. The surge in cancer occurrences can be attributed to factors like urbanization, an aging population, lifestyle alterations, environmental impact, and genetic predispositions. Cancer profiling assists in pinpointing specific molecular or genetic shifts in a tumor, such as genetic mutations or other alterations in the tumor’s DNA, proving to be beneficial in the cycle of cancer treatment. For example, as per the American Cancer Society, a volunteer organization based in the U.S., the numbers projected for new cancer diagnoses and death in 2022 were approximately 1.9 million new cases and 609,360 deaths due to cancer in the United States. Therefore, the uptick in cancer occurrences is a significant driving force behind the growth of the cancer profiling market.
Which Primary Segments of the Cancer Profiling Market Are Driving Growth and Industry Transformations?
The cancer profilingmarket covered in this report is segmented –
1) By Technology: Immunoassays; PCR (Polymerized Chain Reaction); NGS (Next-Generation Sequencing); Microarrays; In-Situ Hybridization
2) By Biomarker Type: Genomic Biomarkers; Protein Biomarkers
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma Cancer; Other Cancers
4) By Application: Research Applications; Clinical Applications; Screening; Diagnostics; Prognostics; Other Applications
Subsegments:
1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Luminex xMAP Technology; Radioimmunoassays
2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR); Digital PCR (dPCR); Reverse Transcription PCR (RT-PCR)
3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES); Targeted Sequencing; RNA Sequencing (RNA-Seq)
4) By Microarrays: DNA Microarrays; RNA Microarrays; SNP Arrays
5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH); Chromogenic In-Situ Hybridization (CISH)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Cancer Profiling Market?# Market?
North America was the largest region in the cancer profiling market in 2024. The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Cancer Profiling Market?
Leading businesses in the cancer profiling industry are prioritizing innovative developments such as broad coverage. This type of testing analyses 517 genes relevant to cancer across about 30 different types of solid tumors. Broad coverage provides an extensive examination of a wide assortment of genetic mutations, molecular targets, or biomarkers. For example, in March 2022, the American biotech firm Illumina, Inc., introduced the TruSight Oncology Comprehensive (TSO) test, marking a significant milestone in cancer diagnosis. This new in-vitro diagnostic test in Europe profiles cancer mutations to direct patients towards targeted therapies. It encompasses 517 genes in approximately 30 solid tumor types, analyzing both DNA and RNA. With a turnaround of four to five days, it offers quicker results and meets the European quality standards with a CE mark, diminishing the requirements for multiple gene assays on various tissue samples.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
What Parameters Are Used to Define the Cancer Profiling Market?
Cancer profiling refers to a diagnostic procedure that is conducted to analyze the genetic information of tumor cells in the body. It provides information about certain molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model